KR102511701B1 - Functional collagen composition using collagen amino acid derived from Aurea Helianthus - Google Patents
Functional collagen composition using collagen amino acid derived from Aurea Helianthus Download PDFInfo
- Publication number
- KR102511701B1 KR102511701B1 KR1020210016090A KR20210016090A KR102511701B1 KR 102511701 B1 KR102511701 B1 KR 102511701B1 KR 1020210016090 A KR1020210016090 A KR 1020210016090A KR 20210016090 A KR20210016090 A KR 20210016090A KR 102511701 B1 KR102511701 B1 KR 102511701B1
- Authority
- KR
- South Korea
- Prior art keywords
- collagen
- composition
- extract
- amino acid
- functional
- Prior art date
Links
- 108010035532 Collagen Proteins 0.000 title claims abstract description 148
- 102000008186 Collagen Human genes 0.000 title claims abstract description 148
- 229920001436 collagen Polymers 0.000 title claims abstract description 148
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 45
- 241000208818 Helianthus Species 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 55
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000002537 cosmetic Substances 0.000 claims abstract description 35
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 27
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 25
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 25
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000004471 Glycine Substances 0.000 claims abstract description 21
- 238000009472 formulation Methods 0.000 claims abstract description 18
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 16
- 230000037303 wrinkles Effects 0.000 claims abstract description 14
- 230000009759 skin aging Effects 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 230000037231 joint health Effects 0.000 claims abstract description 9
- 241000252229 Carassius auratus Species 0.000 claims abstract description 5
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims description 30
- 239000008194 pharmaceutical composition Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 14
- 241000196324 Embryophyta Species 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 7
- 238000000527 sonication Methods 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 34
- 241001465754 Metazoa Species 0.000 abstract description 19
- 235000013376 functional food Nutrition 0.000 abstract description 14
- 239000000463 material Substances 0.000 abstract description 8
- 210000004927 skin cell Anatomy 0.000 abstract description 5
- 238000009210 therapy by ultrasound Methods 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 241000122501 Hypericum x moserianum Species 0.000 abstract 1
- 238000002604 ultrasonography Methods 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 21
- 239000002775 capsule Substances 0.000 description 16
- 235000013311 vegetables Nutrition 0.000 description 16
- 239000006210 lotion Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- -1 fractions Substances 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000686 essence Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000007884 disintegrant Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000007902 hard capsule Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- OOGFPFWTORZYAN-AQHGXSAQSA-N (2s,4r)-4-oxidanylpyrrolidine-2-carboxylic acid Chemical compound O[C@H]1CN[C@H](C(O)=O)C1.O[C@H]1CN[C@H](C(O)=O)C1 OOGFPFWTORZYAN-AQHGXSAQSA-N 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 108010077465 Tropocollagen Proteins 0.000 description 2
- 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 2
- 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 241001233037 catfish Species 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000019985 fermented beverage Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100001223 noncarcinogenic Toxicity 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- UVJWCNFWEYPYSP-SNKMQCGQSA-N 2-aminoacetic acid;(2s,4r)-4-hydroxypyrrolidine-2-carboxylic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound NCC(O)=O.OC(=O)[C@@H]1CCCN1.O[C@H]1CN[C@H](C(O)=O)C1 UVJWCNFWEYPYSP-SNKMQCGQSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 244000151018 Maranta arundinacea Species 0.000 description 1
- 235000010804 Maranta arundinacea Nutrition 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000012419 Thalia geniculata Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0622—Glycine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/064—Proline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/48—Ultrasonic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 금화규(Aurea Helianthus)의 잎, 줄기, 뿌리로부터 추출물, 분획물 또는 이로부터 초음파 처리하여 분리한 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산 유효성분을 함유하는 것을 특징으로 하는 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물을 제공한다. 이때, 상기 금화규(Aurea Helianthus)는 재배 후 음건(陰乾)한 잎, 줄기, 뿌리 중에서 어느 하나를 택일하여 세척하여 이물질을 제거한 후 35~45℃하에서 음건한 다음 분쇄기를 이용하여 분쇄하고, 상기 분쇄물 1kg당 6L의 20%주정을 사용하여 배양기(Shaking incubator)에서 150RPM, 15℃하의 조건에서 2~5일간 추출하며, 상기 추출물의 콜라겐 함유량이 높아 1mm×1mm 두께의 여과망에 4~5회 여과하여 식물체 잔사를 제거한 다음 30~40℃하에서 증발기(Evaporator)로 감압 농축하여 20% 주정을 제거한 후 증류수를 첨가하여 최종 4L, 2.9~3.0% Brix의 추출물을 획득하고, 상기 추출물은 초음파 추출기에서 초음파 진동수(Frequency) 20kHz, 진폭(Amplitude) 60%, 4℃하의 조건에서 3~4시간 동안 초음파 처리하여 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산을 추출한다.
이에 따라 본 발명은, 금화규 속에서 취득한 콜라겐아미노산을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용함은 물론 자유로운 제형의 변화를 손쉽게 추구할 수 있고, 특히 기능적ㆍ유기적 측면에서 콜라겐 합성을 돕는 피부 세포와 유사한 성분인 콜라겐아미노산(GPH; 글리신, 프롤린, 히드록시프롤린) 함량이 아주 높아 인체내 흡수율이 빠르고 피부 수분 양에 관여해 섭취 시 피부 노화와 관절 약화, 혈관 손상을 방지함은 물론 도포 시 피부 보습과 주름 개선되는 등 제품보존성과 안전성이 우수한 효과가 있다.The present invention is an extract or fraction from the leaves, stems, and roots of Aurea Helianthus , or glycine ( Glycin ), proline ( Proline ), and hydroxyproline ( hydroxyproline ), which are separated by ultrasonic treatment. Effectiveness of any one collagen amino acid Provided is a functional collagen composition using collagen amino acids derived from goldfish, characterized in that it contains components. At this time, the gold flower ( Aurea Helianthus ) is washed by selecting any one of the leaves, stems, and roots dried in the shade after cultivation to remove foreign substances, dried in the shade at 35 ~ 45 ℃, and then pulverized using a grinder, Using 6 L of 20% alcohol per 1 kg of pulverized material, extract for 2 to 5 days in a shaking incubator at 150 RPM and 15 ° C. Plant residues were removed by filtration, and concentrated under reduced pressure with an evaporator at 30 to 40° C. to remove 20% alcohol, and then distilled water was added to obtain a final 4L, 2.9 to 3.0% Brix extract. The extract was in an ultrasonic extractor. Ultrasound frequency 20kHz, amplitude 60%, ultrasound treatment for 3 to 4 hours under the conditions of 4 ℃, glycine ( Glycin ), proline ( Proline ), hydroxyproline ( hydroxyproline ), any one collagen amino acid extract
Accordingly, the present invention completely acquires collagen amino acids obtained from Keumhwagyu in the most efficient way, thereby solving the weak point of animal collagen, while improving joint health, skin aging and wrinkles. It can be used as a variety of raw materials for cosmetic raw materials, functional food raw materials, etc., as well as free formulation changes can be easily pursued, and in particular, collagen amino acid (GPH; glycine, proline), a component similar to skin cells that helps collagen synthesis in functional and organic aspects . there is
Description
본 발명은 금화규에 함유된 콜라겐아미노산을 이용한 기능성 콜라겐 조성물에 관한 것으로, 보다 구체적으로는 금화규 속에서 취득한 콜라겐아미노산을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용함은 물론 기능적ㆍ유기적으로 자유로운 제형의 변화를 손쉽게 추구할 수 있는 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물에 관한 것이다.The present invention relates to a functional collagen composition using the collagen amino acid contained in Keumhwagyu, and more specifically, to obtain intact collagen amino acid obtained from Geumhwagyu in the most efficient way, thereby resolving the weakness of animal collagen and maintaining joint health. ㆍGeumhwagyu-derived collagen that can be used as a variety of raw materials for pharmaceutical raw materials effective in improving skin aging and wrinkles, as well as quasi-drug raw materials, cosmetic raw materials, and functional food raw materials, as well as functional and organically free formulation changes It relates to a functional collagen composition using amino acids.
통상, 콜라겐(Collagen)은 경단백질 또는 교원질(膠原質)이라고도 하는데, 무척추동물이나 척추동물 등의 다세포동물에 널리 분포하며 양적으로도 가장 많이 발견되는 것이 경단백질이다. 포유류에서는 전체 단백질의 약 1/4을 차지하기도 하며, 동물의 결합조직을 구성하고 있는 섬유 모양의 장력이 매우 강하고, 힘줄이나 인대에서 힘을 손실 없이 전달한다. 콜라겐의 기본적 구조단위는 분자량 약 30만의 트로포콜라겐(母膠原質)으로, 이분자는 3가닥의 폴리펩티드사슬이 오른쪽 꼬임의 3중 나선구조로 되어 있다. 트로포콜라겐분자는 회합하여 콜라겐섬유(교원섬유)를 형성하는데, 각 분자는 축 방향으로 1/4씩 어긋나게 배열되어 64㎚ 간격의 독특한 줄무늬를 형성하면서 동물의 생장과 함께 분자 사이에 다리 걸친 구조가 생겨 불용성으로 된다. In general, collagen (Collagen) is also called light protein or collagen (膠原質), widely distributed in multicellular animals such as invertebrates and vertebrates, and is the light protein that is found most in quantity. In mammals, it occupies about 1/4 of the total protein, and the fiber-like tension constituting animal connective tissue is very strong, and it transmits power without loss in tendons or ligaments. The basic structural unit of collagen is tropocollagen with a molecular weight of about 300,000, and this molecule has a three-stranded polypeptide chain in a right-twisted triple helix structure. The tropocollagen molecules associate to form collagen fibers (collagen fibers), and each molecule is arranged 1/4 offset in the axial direction to form a unique stripe at 64 nm intervals. and become insoluble.
그러나 콜라겐을 열수나 희산 또는 묽은 알칼리에서 오래 끓이면 물에 녹는 유도단백질 젤라틴으로 변한다. 콜라겐 펩타이드는 아미노산 중에서 유황을 함유한 아미노산은 적은 편이며, 글리신ㆍ프롤린ㆍ히드록시프롤린ㆍ글루타민산 등으로 구성된 섬유성 단백질의 일종으로서, 1,000여개의 아미노산이 모여 가늘고 긴 띠의 형상을 지닌 경단백질이며, 사람의 몸에서 장기를 감싸는 막ㆍ관절 연골ㆍ눈의 각막ㆍ뼈와 피부 등에 주로 존재하고, 특히 피부 속 진피층의 구성 성분으로 매우 중요한 역할을 하고 있다.However, when collagen is boiled for a long time in hot water, dilute acid, or dilute alkali, it turns into gelatin, a induced protein that is soluble in water. Collagen peptides are a type of fibrous protein composed of glycine, proline, hydroxyproline, glutamic acid, etc., with few amino acids containing sulfur among amino acids. , It mainly exists in membranes surrounding organs in the human body, articular cartilage, eye cornea, bones, and skin.
한편, 콜라겐의 주된 기능은 피부의 견고성, 조직의 저항력과 결합력, 세포접착의 지탱 등으로 알려져 있다. 이러한 콜라겐은 고령화 및 자외선 조사에 의한 광노화로 인해 피부의 두께가 얇아지는데, 이러한 현상은 피부의 주름 형성에 밀접한 관련이 있다고 알려져 있다.On the other hand, the main function of collagen is known to be the firmness of the skin, the resistance and binding force of tissues, and the support of cell adhesion. The thickness of the skin becomes thinner due to aging and photoaging by UV irradiation, and this phenomenon is known to be closely related to the formation of wrinkles in the skin.
최근 광범위한 연구가 진전됨에 따라 콜라겐에 대한 다양한 기능이 밝혀지고 있는데, 이러한 콜라겐 펩타이드는 건강식품용, 외과용 및 안과용 치료제 또는 화장품용 첨가제 등으로 사용이 증가되고 있는 추세이다. 이들 콜라겐 펩타이드는 식품학적, 약제학적 및 화장품학적 관점에서 볼 때 제품의 안정성 및 피부, 체내 흡수율에 대한 연구가 현재까지 많이 진행되고 있어 이에 따른 활용방안 등이 활발하게 이루어지고 있는 실정이다.Recently, as extensive research has progressed, various functions of collagen have been revealed. These collagen peptides are increasingly used as health foods, surgical and ophthalmic treatments, or cosmetic additives. As for these collagen peptides, many studies have been conducted so far on product stability and skin and body absorption rates from the food, pharmaceutical, and cosmetic viewpoints, and accordingly, utilization plans are being actively conducted.
이와 관련되는 선행기술로서는 대한민국 공개특허공보 제10-1999-0033721호(선행문헌 1), 대한민국 등록특허공보 제10-0381741호(선행문헌 2), 대한민국 공개특허공보 제10-2004-0014618호(선행문헌 3), 대한민국 등록특허공보 제10-0827389호(선행문헌 4) 등을 들 수 있다.Prior art related to this is Korean Patent Publication No. 10-1999-0033721 (Prior Document 1), Korean Patent Registration No. 10-0381741 (Prior Document 2), Korean Patent Publication No. 10-2004-0014618 ( Prior Document 3), Republic of Korea Patent Registration No. 10-0827389 (Prior Document 4), and the like.
선행문헌 1은 어류(Cat fish) 또는 어류로부터 폐기되어지는 어류 껍질, 머리 부분, 뼈, 내장 등에서 콜라겐을 추출, 분리하는 방법과, 이것으로부터 citric acid 혹은 ascorbic acid로 수용성 콜라겐을 제조하는 방법이 언급되어 있고, 이와 같이 얻어진 수용성 콜라겐(collagen)을 기초로 하여 기능성 화장품(pack, essence)을 제조하는 방법을 제시하고 있다. 또한 콜라겐(collagen)의 함량이 높은 캣 피쉬(Cat fish)의 등뼈와 머리 부분을 이용하여 과즙과 함께 유기산 발효를 하여 기능성 콜라겐(collagen) 발효음료의 제조 방법을 제시한다.
선행문헌 2는 콜라겐 화합물의 어떠한 제조 단계 중에 콜라겐의 기계적 성질을 개선할 수 있는 가교 처리를 동시에 수행할 수 있는 활성물질로 탈취 처리를 받은 해양 동물로부터 수득된 해산물 유래의 콜라겐 화합물을 적어도 부분적으로 함유한 콜라겐 제품을 제시한다.Prior Document 2 at least partially contains a seafood-derived collagen compound obtained from a marine animal subjected to deodorization treatment as an active material capable of simultaneously performing a cross-linking treatment capable of improving the mechanical properties of collagen during any manufacturing step of the collagen compound. We present a collagen product.
선행문헌 3은 오가피(50%), 당귀(10%), 우슬(6%), 두충(5%), 칡(4%), 대추(4%), 감초(1%),를 등분하여 제조가공 추출한 식물성 추출액상과 콜라겐식육(95%), 생강(5%)을 제조 가공 추출한 동물성 추출액상을 혼합하여 숙성 가공하여 각 재료의 효과를 배가시킨 콜라겐 오가피 추출음료를 제조하는 방법을 제시한다.Prior Document 3 is prepared by dividing cucumber (50%), Angelica (10%), Usul (6%), Eucommia (5%), arrowroot (4%), jujube (4%), and licorice (1%) into equal parts. We present a method for manufacturing a collagen ogapi extract beverage in which the effect of each material is doubled by mixing and maturing the processed extracted vegetable extract liquid, collagen meat (95%), and animal extract liquid extracted from manufacturing and processing ginger (5%).
선행문헌 4는 식물성, 동물성 및 해양성의 원료를 전처리 및 열탕처리한 각각의 수용성 콜라겐 용액을 활성탄층에 통과시켜 얻은 수용성 콜라겐 용액을 약산 용액에서 효소반응시키고 활성탄층에 통과시켜 각각의 가수분해된 콜라겐펩타이드를 얻는다. 이들의 콜라겐펩타이드 용액을 각각 또는 일정한 비율로 혼합하여 식품용 또는 화장품용 조성물을 얻는 식품용 콜라겐펩타이드 조성물 및 그 제조방법을 제시한다.Prior Document 4 is a water-soluble collagen solution obtained by passing each of the water-soluble collagen solutions obtained by pretreatment and hot water treatment of vegetable, animal, and marine raw materials through an activated carbon layer, enzymatically reacting the water-soluble collagen solution in a weak acid solution and passing through the activated carbon layer to obtain each hydrolyzed collagen. get the peptide. A collagen peptide composition for food and a manufacturing method for obtaining a food or cosmetic composition by mixing these collagen peptide solutions individually or in a constant ratio are proposed.
그러나 상기의 선행문헌들에 의하면, 그 모두가 콜라겐 등을 이용한 식품 및 화장료 등으로 제안되고 있으나, 콜라겐과 기타 첨가물간의 반응을 거의 고려하지 않았기 때문에 콜라겐이 갖고 있는 효능을 충분히 발휘하지 못하는 문제가 있으며, 더욱이 콜라겐의 효능이 발휘되도록 하더라도 단순히 콜라겐에 의존하는 것이기 때문에 고부가성 물질로의 가치가 떨어지는 단점이 있다.However, according to the preceding documents, all of them are proposed as foods and cosmetics using collagen, etc., but there is a problem in that the efficacy of collagen cannot be sufficiently exerted because the reaction between collagen and other additives is hardly considered. , Moreover, even if the efficacy of collagen is exerted, it simply depends on collagen, so there is a disadvantage in that the value of a high value-added material is reduced.
더군다나, 최근 하드 캡슐 산업은 동물성에서 식물성 캡슐로 수요가 이동하고 있어, 최근 식물성 캡슐에 대한 생산 물량이 빠르게 증대되고 있는 추세로, 식물성 캡슐은 동물성대비 가격이 70-80% 높기 때문에 수익성이 커 최근 식물성 콜라겐 수요가 높아지고 있다. 이렇듯 채식 캡슐은 천연, GMO, 식물성 껍질이며 동물성 유도체, 글루텐 및 변형 당이 없으며, 식물 다당류 (Pululan), 전분 및 HPMC(Hydroxyl Propyl Methyl Celluloses)와 같은 여러 종류로 나눌 수 있다. 이러한 채식 캡슐은 할랄 또는 코셔 인증에 적합한 장점을 가지고 있으며 맛이나 냄새가 없는 순수하고 깨끗하며 우아한 외관, 유용성 성분의 생체 이용률을 개선하는 데 이상적이고 삼키기 쉽고 안전하며 비발암성이며 구조변화가 일어나기어렵다.Moreover, in the recent hard capsule industry, demand is shifting from animal to vegetable capsules, and the production volume of vegetable capsules is rapidly increasing. Demand for plant collagen is increasing. As such, vegetarian capsules are natural, GMO, vegetable shells, free from animal derivatives, gluten and modified sugars, and can be divided into several types such as plant polysaccharides (Pululan), starch and HPMC (Hydroxyl Propyl Methyl Celluloses). These vegetarian capsules have the advantages of being suitable for halal or kosher certification, pure, clean and elegant appearance with no taste or odor, ideal for improving the bioavailability of useful ingredients, easy to swallow, safe, non-carcinogenic and difficult to change in structure.
이에 따라, 콜라겐의 주성분인 히드록시프롤린(hydroxyproline), 하이드로시리신(Hydroxylysine) 등이 들어 있는 식물성 단백질(이하 "식물성 콜라겐"이라 칭함)의 개발로 불안감을 안고 사용하던 동물성 재료로부터 원료를 선택하여 제조된 동물성 콜라겐의 취약성을 보완할 필요성이 대두 되고 있어, 본 출원인은 식물성, 즉 금화규 속에서 취득한 콜라겐아미노산을 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 콜라겐 합성을 돕는 피부 세포와 유사한 성분인 콜라겐아미노산(GPH; 글리신, 프롤린, 히드록시프롤린) 함량이 아주 높아 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용할 수 있음을 확인하고는 본 발명의 개발을 완수하였다.Accordingly, with the development of vegetable protein (hereinafter referred to as “vegetable collagen”) containing the main components of collagen, such as hydroxyproline and hydroxylysine , we select raw materials from animal materials used with anxiety. As the need to compensate for the weakness of manufactured animal collagen is on the rise, the present applicant intactly acquires collagen amino acids obtained from plants, that is, Geumhwagyu, and solves the weakness of animal collagen while helping to synthesize collagen similar to skin cells. The development of the present invention was completed after confirming that the content of collagen amino acid (GPH; glycine, proline, hydroxyproline), which is a component, is very high, so that it can be used as various raw materials for pharmaceutical raw materials, quasi-drug raw materials, cosmetic raw materials, functional food raw materials, etc. did
상기와 같은 종래의 문제점들을 근본적으로 개선하기 위한 본 발명의 목적은, 금화규 속에서 취득한 콜라겐아미노산을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용함은 물론 자유로운 제형의 변화를 손쉽게 추구할 수 있고, 특히 기능적ㆍ유기적 측면에서 콜라겐 합성을 돕는 피부 세포와 유사한 성분인 콜라겐아미노산(GPH; 글리신, 프롤린, 히드록시프롤린) 함량이 아주 높아 인체내 흡수율이 빠르고 피부 수분 양에 관여해 섭취 시 피부 노화와 관절 약화, 혈관 손상을 방지함은 물론 도포 시 피부 보습과 주름 개선되는 등 제품보존성과 안전성이 우수한 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물을 제공하려는데 있다.The purpose of the present invention to fundamentally improve the above conventional problems is to completely acquire collagen amino acids obtained from Geumhwagyu in the most efficient way, thereby solving the weak points of animal collagen while improving joint health, skin aging and wrinkles. In addition to being used as various raw materials for pharmaceutical raw materials that are effective in improvement, raw materials for quasi-drugs, raw materials for cosmetics, raw materials for functional foods, etc., skin cells that can easily pursue changes in free formulations and help synthesize collagen, especially in functional and organic aspects It has a very high content of collagen amino acid (GPH; glycine, proline, hydroxyproline), which is a similar ingredient, so it is absorbed quickly in the body and is involved in the amount of moisture in the skin. It is intended to provide a functional collagen composition using collagen amino acids derived from gold fleas with excellent product preservation and safety, such as moisturizing and wrinkle improvement.
상기 목적을 달성하기 위한 본 발명은, 금화규(Aurea Helianthus)를 재배 후 음건(陰乾)한 잎, 줄기, 뿌리 중에서 어느 하나를 택일하여 세척하여 이물질을 제거한 후 35~45℃하에서 음건한 다음 분쇄기를 이용하여 분쇄하고, 상기 분쇄물 1kg당 6L의 20%주정을 사용하여 배양기(Shaking incubator)에서 150RPM, 15℃하의 조건에서 2~5일간 추출하며, 상기 추출물의 콜라겐 함유량이 높아 1mm×1mm 두께의 여과망에 4~5회 여과하여 식물체 잔사를 제거한 다음 30~40℃하에서 증발기(Evaporator)로 감압 농축하여 20% 주정을 제거한 후 증류수를 첨가하여 최종 4L, 2.9~3.0% Brix의 추출물을 획득하고, 상기 추출물은 초음파 추출기에서 초음파 진동수(Frequency) 20kHz, 진폭(Amplitude) 60%, 4℃하의 조건에서 3~4시간 동안 초음파 처리하여 분리한 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산을 추출한 다음, 상기 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산 유효성분을 함유하는 관절 건강ㆍ피부노화 및 주름 개선용으로 화장품, 식품, 의약품 조성물 중에서 어느 하나로 활용하는 것을 특징으로 한다.The present invention for achieving the above object, after cultivating Aurea Helianthus, selects any one of the shade-dried leaves, stems, and roots to wash them to remove foreign substances, dry them in the shade at 35 to 45 ° C, and then grind them , and extracted for 2 to 5 days in a shaking incubator at 150 RPM and 15 ° C using 6L of 20% alcohol per 1 kg of the pulverized product, and the collagen content of the extract is high, so that the thickness is 1 mm × 1 mm After filtering 4-5 times through a filter net to remove plant residues, concentrate under reduced pressure with an evaporator at 30-40 ° C to remove 20% alcohol, and then add distilled water to obtain a final 4L, 2.9-3.0% Brix extract. , The extract is glycine, proline, and hydroxyproline ( For joint health, skin aging, and wrinkle improvement containing active ingredients of collagen amino acid of any one of glycine, proline, and hydroxyproline after extracting any one of collagen amino acid from hydroxyproline. It is characterized in that it is used as any one of cosmetic, food, and pharmaceutical compositions.
삭제delete
또한, 본 발명에 따르면 상기 콜라겐 조성물은 화장품 조성물이고, 화장품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 화장품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다.In addition, according to the present invention, the collagen composition is a cosmetic composition, and contains 0.1 to 10% by weight of either a collagen amino acid extract or a freeze-dried powder based on the total weight of the cosmetic composition, and the remaining amount is cosmetic It is characterized by containing in an amount of 90 to 99.9% by weight of the carrier acceptable for the formulation.
또한, 본 발명에 따르면 상기 콜라겐 조성물은 식품 조성물이고, 식품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 식품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다.In addition, according to the present invention, the collagen composition is a food composition, and contains 0.1 to 10% by weight of either a collagen amino acid extract or a lyophilized powder based on the total weight of the food composition, and the remaining amount is food It is characterized by containing in an amount of 90 to 99.9% by weight of the carrier acceptable for the formulation.
또한, 본 발명에 따르면 상기 콜라겐 조성물은 관절 건강ㆍ피부노화 및 주름 개선용 의약품 조성물이고, 의약품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 의약품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다.In addition, according to the present invention, the collagen composition is a pharmaceutical composition for joint health, skin aging and wrinkle improvement, and contains 0.1 to 10% by weight of either a collagen amino acid extract or a freeze-dried powder based on the total weight of the pharmaceutical composition And, it is characterized in that it is contained in an amount of 90 to 99.9% by weight of the carrier acceptable for pharmaceutical formulations in the remaining amount.
한편, 이에 앞서 본 명세서 및 특허청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.On the other hand, prior to this, the terms or words used in this specification and claims should not be construed as being limited to ordinary or dictionary meanings, and the inventors use the concept of terms to explain their invention in the best way. Based on the principle that it can be properly defined, it should be interpreted as meaning and concept consistent with the technical spirit of the present invention. Therefore, the embodiments described in this specification and the configurations shown in the drawings are only one of the most preferred embodiments of the present invention, and do not represent all of the technical ideas of the present invention, so various alternatives can be made at the time of this application. It should be understood that there may be equivalents and variations.
이상의 구성 및 작용에서 설명한 바와 같이, 본 발명에 의한 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물은 금화규 속에서 취득한 콜라겐아미노산을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용함은 물론 자유로운 제형의 변화를 손쉽게 추구할 수 있고, 특히 기능적ㆍ유기적 측면에서 콜라겐 합성을 돕는 피부 세포와 유사한 성분인 콜라겐아미노산(GPH; 글리신, 프롤린, 히드록시프롤린) 함량이 아주 높아 인체내 흡수율이 빠르고 피부 수분 양에 관여해 섭취 시 피부 노화와 관절 약화, 혈관 손상을 방지함은 물론 도포 시 피부 보습과 주름 개선되는 등 제품보존성과 안전성이 우수한 효과를 제공한다.As described in the above configuration and action, the functional collagen composition using the collagen amino acid derived from Keumhwagyu according to the present invention completely acquires the collagen amino acid obtained from Geumhwagyu in the most efficient way, and solves the weakness of animal collagen while joint joint It can be used as a variety of raw materials for pharmaceutical raw materials that are effective for health, skin aging and wrinkle improvement, as well as quasi-drug raw materials, cosmetic raw materials, and functional food raw materials. Collagen amino acid (GPH; glycine, proline, hydroxyproline), a component similar to skin cells that help synthesize collagen, is very high in content, so it is quickly absorbed into the body and is involved in the amount of moisture in the skin, preventing skin aging, weakening of joints and blood vessel damage when ingested In addition, it provides excellent effects in product preservation and safety, such as moisturizing the skin and improving wrinkles when applied.
도 1은 본 발명에 따른 금화규 열수추출물을 통한 아미노산 분석을 나타낸 검사성적서.
도 2는 본 발명에 따른 금화규 열수추출물을 통한 히드록시프롤린(hydroxyproline)의 함량을 나타낸 검사성적서.Figure 1 is a test report showing the amino acid analysis through the hot water extract of Geumhwagyu according to the present invention.
Figure 2 is a test report showing the content of hydroxyproline ( hydroxyproline ) through the geumhwagyu hot water extract according to the present invention.
이하, 첨부된 도면을 참조하여 본 발명에 따른 바람직한 실시예를 상세하게 설명한다.Hereinafter, preferred embodiments according to the present invention will be described in detail with reference to the accompanying drawings.
본 발명에서 사용되는 모든 기술용어는, 달리 정의되지 않는 이상, 하기(下記)의 정의를 가지며, 본 발명의 관련 분야에서 통상의 당업자가 일반적으로 이해하는 의미로 사용된다. 또 본 명세서에는 바람직한 방법이나 시료가 기재되나, 이와 유사 내지 동등한 것들도 본 발명의 범주에 포함된다. 또, 본 명세서에 참고문헌으로 기재되는 모든 간행물의 내용은 본 발명에 도입된다. 용어 중 약이라는 것은 참조 양ㆍ수준ㆍ값ㆍ수ㆍ빈도ㆍ퍼센트ㆍ치수ㆍ크기ㆍ양ㆍ중량 또는 길이에 대해 30, 25, 20, 25, 10, 9, 8, 7, 6, 5, 4, 3, 2 또는 1% 정도로 변하는 양ㆍ수준ㆍ값ㆍ수ㆍ빈도ㆍ퍼센트ㆍ치수ㆍ크기ㆍ중량 또는 길이를 의미한다.Unless otherwise defined, all technical terms used in the present invention have the following definitions, and are used in the meaning commonly understood by those skilled in the art in the field related to the present invention. In addition, although preferred methods or samples are described in this specification, similar or equivalent ones are also included in the scope of the present invention. In addition, the contents of all publications described by reference in this specification are incorporated into the present invention. The term approximately means 30, 25, 20, 25, 10, 9, 8, 7, 6, 5, 4 for a reference amount, level, value, number, frequency, percentage, measure, size, amount, weight, or length. It means an amount, level, value, number, frequency, percentage, size, size, weight or length that varies by 3, 2 or 1%.
본 발명은 금화규(Aurea Helianthus)의 잎, 줄기, 뿌리로부터 추출한 콜라겐아미노산을 이용한 기능성 콜라겐 조성물에 관하여 제안한다. 특히 금화규 속에서 취득한 콜라겐아미노산(GPH: Glycine-Proline-Hydroxyproline)을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용할 수 있는 기능성 콜라겐 조성물에 관 한다.The present invention proposes a functional collagen composition using collagen amino acids extracted from the leaves, stems and roots of Aurea Helianthus . In particular, collagen amino acids (GPH: Glycine-Proline-Hydroxyproline) obtained from Keumhwagyu are acquired intact in the most efficient way, and pharmaceutical raw materials that are effective in improving joint health, skin aging, and wrinkles while addressing the weaknesses of animal collagen. It relates to functional collagen compositions that can be used as various raw materials for quasi-drug raw materials, cosmetic raw materials, and functional food raw materials.
본 발명에 따르면 금화규(Aurea Helianthus)의 잎, 줄기, 뿌리로부터 추출물, 분획물 또는 이로부터 초음파 처리하여 분리한 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산 유효성분을 함유하는 것을 특징으로 한다.According to the present invention, extracts, fractions, or extracts from the leaves, stems, and roots of Aurea Helianthus , or glycine ( Glycin ), proline ( Proline ), and hydroxyproline ( hydroxyproline ) separated from the same by ultrasonic treatment, any one collagen amino acid Characterized in that it contains an active ingredient.
한편, 금화규(金花葵)는 학명이 "Aurea Helianthus"로, 일년생 초본식물이며 일명 야생부용이라고도 불린다. 약용가치 때문에 1980년대에 멸종 되었다고 알려졌으나 중국 농업 과학원 교수가 실수로 보관하고 있다가 발견되었다고 한다. 본초강목에 따르면 "식물계의 참대곰"이라고 불릴 만큼 보기 드문 진귀한 약용식물인 금화규(金花葵)는 해열, 해독, 항염증, 진통 효과, 구강 참석 무림, 부종, 화상의 국소 치료, 비장과 위장, 근육 조직 효과, 치료 소화 불량, 식욕 부진, 타박상 등으로 다양한 악성 통증의 치료에 이용된다고 한다.On the other hand, Geumhwagyu (金花葵), whose scientific name is " Aurea Helianthus ", is an annual herbaceous plant and is also called wild bouillon. It was known that it became extinct in the 1980s because of its medicinal value, but it is said that a professor at the Chinese Academy of Agricultural Sciences accidentally kept it and discovered it. According to Herbal Medicine, Geumhwagyu (金花葵), a rare medicinal plant that is so rare that it is called "the true bear of the vegetable world," has antipyretic, detoxifying, anti-inflammatory, analgesic effects, oral pain, swelling, topical treatment of burns, spleen and It is said to be used in the treatment of various malignant pains such as gastric and muscle tissue effects, therapeutic indigestion, anorexia, and bruises.
또한, 천연 식물성 에스트로겐이 풍부하여 중년 갱년기 증후군을 감소시키거나 연장을 도와준다고 합니다. 현대 의학 연구에 따르면 진통제, 항 뇌허혈 및 구강 궤양의 치료 내분비, 면역 시스템을 조절 바디 저항을 증가, 심혈관 기능 및 미세 순환 개선 신체의 항산화, 항 심장 허혈, 저산소증, 염증, 통증 마을, 항 피로, 노화 방지, 항암, 콜레스테롤 저하 효과를 향상시킬 수 있다. 금화규의 꽃은 7월말부터 따서 잘게 찢어서 말리는데 콜라겐이 풍부하기 때문에 식품. 화장품 및 차의 원료가 사용되며, 금화규에는 꽃과 잎은 물론 꽃대와 뿌리에도 콜라겐이 풍부하며 금화규 꽃의 봉오리는 강장작용이 탁월하여 다양한 생리활성 물질을 함유하고 있어 다양한 용도에 이용되고 있다.In addition, it is said to help reduce or prolong middle-aged menopausal syndrome as it is rich in natural phytoestrogens. According to modern medical research, analgesic, anti-cerebral ischemia and treatment of oral ulcers, regulate endocrine, immune system, increase body resistance, improve cardiovascular function and microcirculation, anti-oxidation of the body, anti-cardiac ischemia, hypoxia, inflammation, pain village, anti-fatigue, aging It can improve anti-cancer, cholesterol-lowering effects. Geumhwagyu flowers are picked from the end of July, torn into small pieces, and dried. Because they are rich in collagen, they are a food. It is used as a raw material for cosmetics and tea. Geumhwagyu is rich in collagen not only in flowers and leaves, but also in flower stalks and roots. .
이러한 금화규(Aurea Helianthus)의 잎, 줄기, 뿌리로부터 추출물, 분획물 또는 이로부터 초음파 처리하여 분리한 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산 유효성분을 함유한다. 따라서 본 발명에서 "추출물" 은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획물 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Extracts, fractions, or extracts from the leaves, stems, and roots of Aurea Helianthus , or collagen amino acid active ingredients of any one of glycine, proline , and hydroxyproline separated by sonication therefrom contain Therefore, in the present invention, "extract" is a concept including all extracts, fractions, and purified products obtained in each step of extraction, fractionation, or purification, and dilutions, concentrates, or dried products thereof.
이때, 본 발명에 의한 세부 구성에 의하면 상기 금화규(Aurea Helianthus)는 재배 후 음건(陰乾)한 잎, 줄기, 뿌리 중에서 어느 하나를 택일하여 세척하여 이물질을 제거한 후 35~45℃하에서 음건한 다음 분쇄기를 이용하여 분쇄하고, 상기 분쇄물 1kg당 6L의 20%주정을 사용하여 배양기(Shaking incubator)에서 150RPM, 15℃하의 조건에서 2~5일간 추출하며, 상기 추출물의 콜라겐 함유량이 높아 1mm×1mm 두께의 여과망에 4~5회 여과하여 식물체 잔사를 제거한 다음 30~40℃하에서 증발기(Evaporator)로 감압 농축하여 20% 주정을 제거한 후 증류수를 첨가하여 최종 4L, 2.9~3.0% Brix의 추출물을 획득하는 것을 특징으로 한다. 이는, 금화규를 재배 후 음건(陰乾)한 잎, 줄기, 뿌리 중에서 어느 하나를 택일한 다음, 정제수로 세척하여 불순물(흙 및 이물질)을 제거한 후 40℃하에 음건하고, 분쇄기를 이용하여 금화규 1kg에 대하여 10∼100㎛이하의 크기로 잘게 분쇄한다. 이어서, 금화규 뿌리 1kg당 6L의 20%주정을 사용하여 배양기(Shaking incubator)에서 150RPM, 15℃하의 조건에서 2~5일간, 바람직하게는 3일간 추출한다. 이어서, 상기 추출물은 콜라겐 함유량이 높아 1mmㅧ1mm 두께의 여과망에 4~5회 여과하여 식물체 잔사를 제거한 다음, 30~40℃하에서, 바람직하게는 37℃하에서 증발기(Evaporator)에서 감압 농축하여 20% 주정을 제거한 후 증류수를 첨가하여 최종 4L의 추출물을 취득한다. 이러한 추출물의 Brix는 2.9~3.0%로 측정된다.At this time, according to the detailed configuration according to the present invention, the Aurea Helianthus is washed by selecting any one of the leaves, stems, and roots dried in the shade after cultivation to remove foreign substances, and then dried in the shade at 35 to 45 ° C. Pulverized using a grinder, and extracted for 2 to 5 days in a shaking incubator at 150 RPM and 15 ° C using 6 L of 20% alcohol per 1 kg of the ground material, and the collagen content of the extract is high, so that 1 mm × 1 mm Plant residues were removed by filtering 4-5 times through a thick filter net, then concentrated under reduced pressure with an evaporator at 30-40°C to remove 20% alcohol, and then distilled water was added to obtain a final 4L, 2.9-3.0% Brix extract. It is characterized by doing. After cultivating Geumhwagyu, select one of the shade-dried leaves, stems, and roots, wash it with purified water to remove impurities (soil and foreign matter), dry it in the shade at 40 ° C, and use a grinder to It is finely pulverized to a size of 10 to 100 μm or less per 1 kg. Then, using 6 L of 20% alcohol per 1 kg of Geumhwagyu roots, extract for 2 to 5 days, preferably 3 days, under conditions of 150 RPM and 15 ° C in a shaking incubator. Subsequently, the extract has a high collagen content and is filtered 4 to 5 times through a 1mm × 1mm thick filter net to remove plant residues, and then concentrated under reduced pressure in an evaporator at 30 to 40° C., preferably at 37° C., to obtain 20% After removing the alcohol, distilled water is added to obtain a final 4L extract. The Brix of these extracts was measured at 2.9-3.0%.
한편, 상기한 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 예를 들면, 본 발명의 기능성 콜라겐 조성물에 포함되는 금화규 추출물은 상기한 추출물을 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다.On the other hand, the above extract may be further subjected to a conventional fractionation process, and may be purified using a conventional purification method. For example, the Geumhwagyu extract included in the functional collagen composition of the present invention can be prepared in a powder state by an additional process such as freeze-drying or spray-drying the extract.
또한, 본 발명의 상기 여과망은 추출액으로부터 부유하는 고체 입자를 제거하는 과정으로, 면, 나일론, 종이 중 선택되는 하나를 이용하여 입자를 걸러 내거나, 한외여과, 냉동여과법, 원심분리법 등을 이용할 수 있으나, 이에 제한되지 않는다. 또한, 크로마토그래피 (크기, 전하, 소수성 또는 친화성에 따른 크로마토그래피)에 의한 분리 과정을 추가로 포함할 수도 있다.In addition, the filter net of the present invention is a process of removing floating solid particles from the extract, and can filter out particles using one selected from cotton, nylon, and paper, or use ultrafiltration, cryofiltration, centrifugation, etc. , but not limited thereto. In addition, a separation process by chromatography (chromatography according to size, charge, hydrophobicity or affinity) may be further included.
한편, 본 발명의 상기 추출물은 일예로, 동결건조, 진공건조, 열풍건조, 분무건조, 감압건조, 포말건조, 고주파건조 및 적외선건조일 수 있으나, 이에 제한되지 않는다. 경우에 따라 최종 건조된 추출물을 분쇄하는 공정을 추가로 포함할 수도 있다.On the other hand, the extract of the present invention may be freeze-dried, vacuum-dried, hot-air-dried, spray-dried, vacuum-dried, foam-dried, radiofrequency-dried, and infrared-dried, for example, but is not limited thereto. In some cases, a step of pulverizing the finally dried extract may be further included.
또한, 본 발명에 의한 세부 구성에 의하면 상기 추출물은 초음파 추출기에서 초음파 진동수(Frequency) 20kHz, 진폭(Amplitude) 60%, 4℃하의 조건에서 3~4시간 동안 초음파 처리하여 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산을 추출하는 것을 특징으로 한다. 상기한 금화규 추출 방법을 통해 취득한 추출물은 하기의 표 1처럼 초음파 처리를 통해 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산을 추출한다. 이는 상기 취득한 추출물을 초음파 추출기에서 초음파 진동수(Frequency) 20kHz, 진폭(Amplitude) 60%, 4℃하의 조건에서 3~4시간 동안 초음파 처리하여 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline) 중 어느 하나의 콜라겐아미노산을 추출한다.In addition, according to the detailed configuration according to the present invention, the extract is ultrasonically treated for 3 to 4 hours under the conditions of an ultrasonic frequency of 20 kHz, an amplitude of 60%, and 4 ° C in an ultrasonic extractor to obtain glycine and proline ( It is characterized by extracting any one of collagen amino acids from Proline ) and hydroxyproline . In the extract obtained through the above-mentioned Geumhwagyu extraction method, any one of collagen amino acids among glycine , proline , and hydroxyproline is extracted through sonication as shown in Table 1 below. This extract is obtained by ultrasonication of the obtained extract in an ultrasonic extractor at an ultrasonic frequency of 20 kHz, an amplitude of 60%, and ultrasonic treatment for 3 to 4 hours at 4 ° C to obtain glycine, proline , and hydroxyproline . ) Extract any one of the collagen amino acids.
이처럼, 도 1처럼 KFRI 한국식품연구원을 통해 추출물에 대한 아미노산 분석한 결과를 보면, 글리신(Glycin)이 517.7㎎/100g, 프롤린(Proline)이 246.3㎎/100g, 리신(lysine)이 277㎎/100g로 다양한 아미노산 등이 풍부하게 함유되고, 도 2처럼 한국기능식품연구원을 통해 추출물에 대한 히드록시프롤린(hydroxyproline)의 함유량을 분석한 결과를 보면, 히드록시프롤린(hydroxyproline)이 0.28㎎/g로 풍부하게 함유되어 식물성 콜라겐으로 확인되었으며, 그 외에도 보습, 피부 노화 방지 등에서 유용성을 보이는 글루타민산(Glutamic acid), 아스파르트산(Aspartic acid), 알기닌(Arginine) 등 다양한 아미노산이 풍부하게 함유됨이 확인되었다.As such, looking at the amino acid analysis results for the extract through the KFRI Korea Food Research Institute as shown in Figure 1, glycine ( Glycin ) is 517.7㎎ / 100g, proline ( Proline ) is 246.3㎎ / 100g, lysine ( lysine ) is 277㎎ / 100g As a result of analyzing the content of hydroxyproline in the extract through the Korea Functional Food Research Institute, as shown in FIG. 2, hydroxyproline is abundant at 0.28 mg/g. In addition, it was confirmed that various amino acids such as glutamic acid , aspartic acid , and arginine , which are useful in moisturizing and preventing skin aging, are abundantly contained.
이때, 본 발명의 일실시예에 따르면 상기 콜라겐 조성물은 화장품 조성물의 전체 중량을 기준으로 하여 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 화장품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다. 이처럼 상기 금화규로부터 추출한 기능성 콜라겐 조성물은 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline)이 풍부하게 함유되어 식물성 콜라겐으로 확인되고, 이러한 기능성 콜라겐 조성물을 화장품 조성물 제조에 이용할 수 있는데, 화장품 조성물은 기능성 콜라겐 조성물이 전체 중량을 기준으로 살펴볼 때, 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 내외의 범위로 유지하는 것이 바람직할 뿐만 아니라 품질경쟁력과 가격경쟁력 측면에서 볼 때도 가장 적절한 것으로 사료된다. 이외에도 잔량(殘量)은 화장품 조성물에 통상적으로 활용되는 성분들을 허용되는 담체를 전체 중량에 대하여 약 90~99.9중량% 내외의 범위로 함유한다. 그리고 통상적으로 활용되는 물질로는, 예컨대 항산화제ㆍ안정화제ㆍ용해화제ㆍ비타민ㆍ안료 및 향료와 같이 통상적인 보조제 등을 함유할 수 있다.At this time, according to one embodiment of the present invention, the collagen composition contains 0.1 to 10% by weight of either an extract or a lyophilized powder based on the total weight of the cosmetic composition, and the remaining amount is a cosmetic preparation Characterized in that it contains in an amount of 90 to 99.9% by weight of the carrier allowed for. In this way, the functional collagen composition extracted from the Keumhwagyu is identified as vegetable collagen as it contains abundant glycine , proline , and hydroxyproline , and such a functional collagen composition can be used for manufacturing a cosmetic composition, When looking at the cosmetic composition based on the total weight of the functional collagen composition, it is desirable to select either extract or freeze-dried powder and maintain it within the range of 0.1 to 10% by weight, as well as quality competitiveness and price competitiveness. It is also considered the most appropriate. In addition, the remaining amount contains the components commonly used in cosmetic compositions in the range of about 90 to 99.9% by weight based on the total weight of the acceptable carrier. In addition, as materials commonly used, for example, antioxidants, stabilizers, solubilizers, vitamins, pigments, and flavoring agents, etc. may be included.
즉, 상기 기능성 콜라겐 조성물의 유효성분으로 함유하는 화장료 조성물로 제조되는 화장품은 스킨ㆍ로션ㆍ세럼ㆍ에센스ㆍUV크림ㆍ비비크림ㆍ영양크림ㆍ마사지 크림으로 구성된 군(群)으로부터 선택된 어느 하나의 제형으로 제조 가능한데, 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있는데, 예를 들면 용액ㆍ현탁액ㆍ유탁액ㆍ페이스트ㆍ겔ㆍ크림ㆍ로션ㆍ파우더ㆍ비누ㆍ계면활성제-함유 클렌징ㆍ오일ㆍ분말 파운데이션ㆍ유탁액 파운데이션ㆍ왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 일반적인 유화 제형 및 가용화 제형의 형태로도 제조할 수 있다. 유화 제형의 화장품으로는 영양화장수ㆍ크림ㆍ에센스 등이 있으며, 가용화 제형의 화장품으로는 유연화장수가 될 수 있으며 이에 한정되는 것은 아니다. That is, the cosmetic product made of the cosmetic composition containing the functional collagen composition as an active ingredient is any one formulation selected from the group consisting of skin, lotion, serum, essence, UV cream, BB cream, nutrient cream, and massage cream. It can be produced in any formulation commonly produced in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, It can be formulated into powder foundation, emulsion foundation, wax foundation, spray, etc., but it can also be prepared in the form of general emulsion formulation and solubilization formulation. Emulsion-type cosmetics include nutritional lotion, cream, and essence, and solubilization-type cosmetics may include softening lotion, but are not limited thereto.
이외에 별도의 화장품 제형으로, 예를 들면 용액ㆍ겔ㆍ고체 또는 반죽 무수 생성물ㆍ수상에 유상을 분산시켜 얻은 에멀젼ㆍ현탁액ㆍ마이크로 에멀젼ㆍ마이크로 캡슐ㆍ미세과립구 또는 이온형(리포좀)ㆍ비 이온형의 소낭 분산제의 형태ㆍ크림ㆍ스킨ㆍ로션ㆍ파우더ㆍ연고ㆍ스프레이 또는 콘실 스틱(conceal stick)의 형태로도 제공될 수 있다. In addition, as a separate cosmetic formulation, for example, solution, gel, solid or kneaded anhydrous product, emulsion obtained by dispersing oil phase in water phase, suspension, microemulsion, microcapsule, microgranule or ionic type (liposome), non-ionic type It may also be provided in the form of a follicular dispersion, cream, skin, lotion, powder, ointment, spray or conceal stick.
또한, 화장품 조성물은 화장품 제제에 허용되는 담체 중 추가로 지방 물질ㆍ유기 용매ㆍ용해제ㆍ농축제 및 겔화제ㆍ연화제ㆍ항산화제ㆍ현탁화제ㆍ안정화제ㆍ발포제(foaming agent)ㆍ방향제ㆍ계면활성제ㆍ물ㆍ이온형 또는 비 이온형 유화제ㆍ충전제ㆍ금속이온 봉쇄제 및 킬레이트화제ㆍ보존제ㆍ비타민ㆍ차단제ㆍ습윤화제ㆍ필수 오일ㆍ염료ㆍ안료ㆍ친수성 또는 친유성 활성제ㆍ지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수도 있다 할 것이다. In addition, the cosmetic composition may include a fatty substance, an organic solvent, a solubilizing agent, a thickening agent, a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, Water, ionic or nonionic emulsifier, filler, metal ion sequestering and chelating agent, preservative, vitamin, blocking agent, humectant, essential oil, dye, pigment, hydrophilic or lipophilic active agent, lipid vesicle or commonly used in cosmetics It may also contain adjuvants commonly used in the field of cosmetology or dermatology, such as any other ingredient that is
그리고 상기한 성분들은 피부과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다. 즉, 예를 들어 수렴화장수ㆍ유연화장수ㆍ영양화장수ㆍ각종 크림ㆍ에센스ㆍ팩ㆍ파운데이션 등과 같은 화장품류 등이 있는데, 구체적인 제형으로서는 스킨로션ㆍ스킨 소프너ㆍ스킨토너ㆍ아스트린젠트ㆍ로션ㆍ밀크로션ㆍ모이스처 로션ㆍ영양로션ㆍ맛사지크림ㆍ영양크림ㆍ모이스처 크림ㆍ핸드크림ㆍ에센스ㆍ영양에센스 등의 제형을 포함한다.In addition, the above components may be introduced in an amount generally used in the field of dermatology. That is, for example, there are cosmetics such as astringent lotion, softening lotion, nourishing lotion, various creams, essences, packs, foundations, etc. Specific formulations include skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, and moisture. It includes formulations such as lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, hand cream, essence, and nutrition essence.
또한, 본 발명의 다른 실시예에 따르면 상기 콜라겐 조성물은 식품 조성물의 전체 중량을 기준으로 하여 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 식품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다. 이처럼 상기 금화규로부터 추출한 기능성 콜라겐 조성물은 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline)이 풍부하게 함유되어 식물성 콜라겐으로 확인되고, 이러한 기능성 콜라겐 조성물을 식품 조성물 제조에 이용할 수 있는데, 식품 조성물은 기능성 콜라겐 조성물이 전체 중량을 기준으로 살펴볼 때, 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 내외의 범위로 유지하는 것이 바람직할 뿐만 아니라 품질경쟁력과 가격경쟁력 측면에서 볼 때도 가장 적절한 것으로 사료된다. 이외에도 잔량(殘量)은 식품 조성물에 통상적으로 활용되는 성분들을 허용되는 담체를 전체 중량에 대하여 약 90~99.9중량% 내외의 범위로 함유한다. 그리고 통상적으로 활용되는 물질로는, 예컨대 기능성 콜라겐 조성물의 유효성분 외에 통상의 식품 조성물과 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.In addition, according to another embodiment of the present invention, the collagen composition contains 0.1 to 10% by weight of either an extract or a freeze-dried powder based on the total weight of the food composition, and the remaining amount is a food preparation Characterized in that it contains in an amount of 90 to 99.9% by weight of the carrier allowed for. In this way, the functional collagen composition extracted from the goldfish is identified as vegetable collagen because it contains abundant glycine , proline , and hydroxyproline , and this functional collagen composition can be used for preparing food compositions, When looking at the functional collagen composition based on the total weight of the food composition, it is desirable to select either extract or freeze-dried powder and maintain it within the range of 0.1 to 10% by weight, as well as quality competitiveness and price competitiveness. It is also considered the most appropriate. In addition, the remaining amount contains the components commonly used in food compositions in the range of about 90 to 99.9% by weight based on the total weight of the acceptable carrier. In addition to the active ingredients of the functional collagen composition, for example, various flavoring agents or natural carbohydrates may be included as additional ingredients, as in conventional food compositions.
즉, 상기 기능성 콜라겐 조성물의 유효성분으로 함유하는 식품 조성물로 제조되는 식품은 담체로, 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등 디사카라이드, 예를 들어 말토스, 슈크로스 등 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상기한 향미제는 천연 향미제(타우마틴), 레바우디오시드 A, 글리시르히진 등 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 식품 조성물은 상기 약제학적 조성물과 동일한 방식으로 제제화되어 기능성 식품으로 이용하거나, 각종 식품에 첨가할 수 있다. 예를 들어, 음료류, 육류, 초코렛, 식품류, 과자류, 피자, 라면, 기타 면류, 껌류, 사탕류, 아이스크림류, 알코올 음료류, 비타민 복합제 및 건강 보조식품류 등이 있다. That is, the food prepared from the food composition containing the functional collagen composition as an active ingredient is used as a carrier, and examples of natural carbohydrates include monosaccharides such as glucose and disaccharides such as fructose, such as maltose and sugar and polysaccharides such as dextrin, cyclodextrin, and the like, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the above flavors, natural flavors (such as thaumatin), rebaudioside A, glycyrrhizin, and the like, and synthetic flavors (such as saccharin and aspartame) can be advantageously used. The food composition may be formulated in the same way as the pharmaceutical composition and used as a functional food or added to various foods. For example, there are beverages, meat, chocolate, foods, confectionery, pizza, ramen, other noodles, chewing gum, candy, ice cream, alcoholic beverages, vitamin complexes, and health supplements.
또한, 상기 식품 조성물은 유효성분인 기능성 콜라겐 조성물 외에 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 식품 조성물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition, the food composition, in addition to the functional collagen composition as an active ingredient, various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohol, carbonating agents used in carbonated beverages, and the like. In addition, the food composition may contain fruit flesh for preparing natural fruit juice, fruit juice beverages, and vegetable beverages.
이외에도, 식품 조성물은 정제, 캡슐, 분말, 과립, 액상, 환 등의 형태로 건강기능식품으로 제조 및 가공할 수 있는데, 이는 건강기능식품에 관한 법률 제10219호에 따른 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 제조 및 가공한 식품을 말하며, 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건 용도에 유용한 효과를 얻을 목적으로 섭취하는 것을 의미한다. In addition, food compositions can be manufactured and processed into functional health foods in the form of tablets, capsules, powders, granules, liquids, pills, etc. It refers to food manufactured and processed using ingredients B, and refers to intake for the purpose of obtaining useful effects for health purposes such as adjusting nutrients for the structure and function of the human body or physiological functions.
한편, 건강기능식품은 통상의 식품 첨가물을 포함할 수 있으며, 식품 첨가물로서의 적합 여부는 다른 규정이 없는 한, 식품의약품안전청에 승인된 식품 첨가물 공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다. 예를 들어, 정제 형태의 건강기능식품은 본 발명의 유효성분인 기능성 콜라겐 조성물을 부형제, 결합제, 붕해제 및 다른 첨가제와 혼합한 혼합물을 통상의 방법으로 과립화한 다음, 활택제 등을 넣어 압축성형하거나, 상기 혼합물을 직접 압축 성형할 수 있다. 캡슐 형태의 건강기능식품 중 경질 캡슐제는 통상의 경질 캡슐에 본 발명의 유효성분인 기능성 콜라겐 조성물을 부형제 등의 첨가제와 혼합한 혼합물을 충진하여 제조할 수 있으며, 연질 캡슐제는 기능성 콜라겐 조성물을 부형제 등의 첨가제와 혼합한 혼합물을 젤라틴과 같은 캡슐기제에 충진하여 제조할 수 있다. 상기 연질 캡슐제는 필요에 따라 글리세린 또는 소르비톨 등의 가소제, 착색제, 보존제 등을 함유할 수 있다. 환 형태의 건강기능식품은 본 발명의 유효성분인 기능성 콜라겐 조성물과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 성형하여 조제할 수 있으며, 필요에 따라 백당이나 다른 제피제로 제피할 수 있으며, 또는 전분, 탈크와 같은 물질로 표면을 코팅할 수도 있다. 과립 형태의 건강기능식품은 본 발명의 유효성분인 기능성 콜라겐 조성물과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 입상으로 제조할 수 있으며, 필요에 따라 착향제, 교미제 등을 함유할 수 있다.On the other hand, health functional foods may contain normal food additives, and the suitability as food additives is determined according to the general rules of food additives and general test methods approved by the Korea Food and Drug Administration, unless otherwise specified. and judged by criteria. For example, a health functional food in the form of a tablet is obtained by granulating a mixture obtained by mixing a functional collagen composition, which is an active ingredient of the present invention, with excipients, binders, disintegrants, and other additives in a conventional manner, and then adding a lubricant and compressing the mixture. Or, the mixture may be directly compression molded. Among health functional foods in the form of capsules, hard capsules can be prepared by filling a mixture of a functional collagen composition, which is the active ingredient of the present invention, with additives such as excipients, in a conventional hard capsule, and soft capsules contain a functional collagen composition. It can be prepared by filling a mixture with additives such as excipients into a capsule base such as gelatin. The soft capsule may contain a plasticizer such as glycerin or sorbitol, a coloring agent, a preservative, and the like, if necessary. The health functional food in the form of a pill can be prepared by molding a mixture of a functional collagen composition, which is an active ingredient of the present invention, and excipients, binders, disintegrants, etc. It can be coated, or the surface can be coated with a material such as starch or talc. A health functional food in the form of a granule can be prepared in granular form by a conventionally known method of mixing a functional collagen composition, which is an active ingredient of the present invention, with excipients, binders, disintegrants, etc., and, if necessary, flavoring agents and corrigents etc. may be included.
또한, 본 발명의 또 다른 실시예에 따르면 상기 콜라겐 조성물은 의약품 조성물의 전체 중량을 기준으로 하여 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 의약품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 한다. 이처럼 상기 금화규로부터 추출한 기능성 콜라겐 조성물은 글리신(Glycin)과 프롤린(Proline), 히드록시프롤린(hydroxyproline)이 풍부하게 함유되어 식물성 콜라겐으로 확인되고, 이러한 기능성 콜라겐 조성물을 의약품 조성물 제조에 이용할 수 있는데, 의약품 조성물은 기능성 콜라겐 조성물이 전체 중량을 기준으로 살펴볼 때, 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 내외의 범위로 유지하는 것이 바람직할 뿐만 아니라 품질경쟁력과 가격경쟁력 측면에서 볼 때도 가장 적절한 것으로 사료된다. 이외에도 잔량(殘量)은 의약품 조성물에 통상적으로 활용되는 성분들을 허용되는 담체를 전체 중량에 대하여 약 90~99.9중량% 내외의 범위로 함유한다. 그리고 통상적으로 활용되는 물질로는, 예컨대 기능성 콜라겐 조성물의 유효성분 외에 통상의 의약품 조성물과 같이 약제학적으로 적합하고 생리학적으로 허용되는 보조제를 사용하여 제조될 수 있으며, 상기 보조제로는 부형제, 붕해제, 감미제, 결합제, 피복제, 팽창제, 윤활제, 활택제 또는 향미제 등을 사용할 수 있고, 상기 약제학적 조성물은 투여를 위해서 상기 기재한 유효성분 이외에 추가로 약제학적으로 허용 가능한 담체를 1종 이상 포함하여 약제학적 조성물로 바람직하게 제제화할 수 있다.In addition, according to another embodiment of the present invention, the collagen composition contains 0.1 to 10% by weight of either an extract or a freeze-dried powder based on the total weight of the pharmaceutical composition, and the remaining amount is a pharmaceutical It is characterized by containing in an amount of 90 to 99.9% by weight of the carrier acceptable for the formulation. In this way, the functional collagen composition extracted from the Keumhwagyu is identified as vegetable collagen as it contains abundant glycine , proline , and hydroxyproline , and this functional collagen composition can be used for the preparation of pharmaceutical compositions, When looking at the functional collagen composition based on the total weight of the pharmaceutical composition, it is desirable to select either extract or freeze-dried powder and maintain it within the range of 0.1 to 10% by weight, as well as quality competitiveness and price competitiveness. It is also considered the most appropriate. In addition, the remaining amount contains the components commonly used in pharmaceutical compositions in the range of about 90 to 99.9% by weight based on the total weight of the acceptable carrier. And, as a commonly used material, for example, in addition to the active ingredient of a functional collagen composition, it can be prepared using pharmaceutically suitable and physiologically acceptable adjuvants, such as conventional pharmaceutical compositions, and the adjuvants include excipients and disintegrants , Sweeteners, binders, coating agents, expanding agents, lubricants, lubricants, or flavoring agents may be used, and the pharmaceutical composition includes one or more pharmaceutically acceptable carriers in addition to the above-described active ingredients for administration. It can be preferably formulated into a pharmaceutical composition.
즉, 상기 의약품 조성물의 제제 형태는 특별히 제한되지 않으며, 해당분야의 적절한 방법으로 Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA에 개시되어 있는 방법을 이용하여 각 질환에 따라 또는 성분에 따라 바람직하게 제제화 할 수 있다.That is, the formulation form of the pharmaceutical composition is not particularly limited, and can be preferably formulated according to each disease or component using a method disclosed in Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA as an appropriate method in the field. can
또한, 의약품 조성물은 피부 외용제 조성물일 수 있다. 피부 외용 약제학적 조성물은 자외선으로부터 피부보호 효과를 갖는 피부외용제로서 크림, 젤, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 또는 카타플라스마제의 피부 외용제 형태의 약학조성물로 제조하여 사용할 수 있으나, 이에 한정하는 것은 아니다. 이러한 피부 외용 약제학적 조성물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다.In addition, the pharmaceutical composition may be a composition for external application on the skin. The pharmaceutical composition for external application to the skin is a pharmaceutical composition for external application to the skin having a skin protection effect from ultraviolet rays, such as a cream, gel, patch, spray, ointment, warning agent, lotion, liniment, pasta or cataplasma. It can be prepared and used, but is not limited thereto. A preferred dosage of the pharmaceutical composition for external application to the skin varies depending on the condition and weight of the patient, the severity of the disease, the type of drug, the route and duration of administration, but can be appropriately selected by those skilled in the art.
이외에도, 의약품 조성물은 의약외품 조성물 제조로도 이용할 수 있는데, "의약외품"은 사람이나 동물의 질병을 진단, 치료, 개선, 경감, 처치 또는 예방할 목적으로 사용되는 물품들 중 의약품보다 작용이 경미한 물품들을 의미하는 것으로, 예를 들어 약사법에 따르면 의약외품이란 의약품의 용도로 사용되는 물품을 제외한 것으로, 사람ㆍ동물의 질병 치료나 예방에 쓰이는 제품, 인체에 대한 작용이 경미하거나 직접 작용하지 않는 제품 등이 포함되고, 예를 들면 바디 클렌저, 소독 청결제, 세정제, 주방용 세정제, 청소용 세정제, 치약, 가글제, 물티슈, 세제, 비누, 핸드워시, 헤어세정제, 헤어 유연제, 가습기 충진제, 마스크, 연고제 및 필터 충진제로 이루어진 군에서 선택되는 제형으로 제조할 수 있으나, 이에 제한되는 것은 아니다.In addition, pharmaceutical compositions can also be used for the manufacture of quasi-drug compositions. "Quasi-drugs" refer to products with milder effects than pharmaceuticals among items used for the purpose of diagnosing, treating, improving, mitigating, treating or preventing human or animal diseases. For example, according to the Pharmaceutical Affairs Act, quasi-drugs are products excluding items used for pharmaceutical purposes, including products used for the treatment or prevention of human or animal diseases, products with minor or no direct action on the human body, etc. , for example in the group consisting of body cleansers, disinfectant cleansers, detergents, kitchen cleaners, cleaning cleaners, toothpastes, gargles, wet wipes, detergents, soaps, hand washes, hair washes, hair softeners, humidifier fillers, masks, ointments and filter fillers It can be prepared in a selected formulation, but is not limited thereto.
특히, 본 발명의 의약품 조성물 중 캡슐로도 제조 가능한데, 한편, 최근 하드 캡슐 산업은 동물성에서 식물성 캡슐로 수요가 이동하고 있어, 최근 식물성 캡슐에 대한 생산 물량이 빠르게 증대되고 있다. 식물성 캡슐은 동물성 대비 가격이 70-80% 높기 때문에 수익성이 커 최근 콜라겐 수요가 높아지고 있다. 세계 식물성 캡슐 시장의 가치는 2020년에 1억 1,510만 US $로 2026년 말까지 2억 2,960만 US $에 이를 것으로 예상되며, 2021-2026년 동안 연평균 10.0% 성장할 것으로 예상된다.In particular, the pharmaceutical composition of the present invention can also be manufactured into capsules. On the other hand, in the recent hard capsule industry, demand has shifted from animal to vegetable capsules, and the production volume of vegetable capsules is rapidly increasing. Since vegetable capsules are 70-80% more expensive than animal-based capsules, demand for collagen is rising due to high profitability. The global vegetable capsules market is valued at 115.1 million US$ in 2020 and is expected to reach 229.6 million US$ by the end of 2026, growing at a CAGR of 10.0% during 2021-2026.
이러한 채식 캡슐은 천연, GMO, 식물성 껍질이며 동물성 유도체, 글루텐 및 변형 당이 없다. 오늘날 채식 캡슐은 식물 다당류(Pululan), 전분 및 HPMC (Hydroxyl Propyl Methyl Celluloses)와 같은 여러 종류로 나눌 수 있다. 채식 캡슐은 할랄 또는 코셔 인증에 적합한 장점을 가지고 있다. 맛이나 냄새가 없는 순수하고 깨끗하며 우아한 외관, 유용성 성분의 생체 이용률을 개선하는 데 이상적이며 삼키기 쉽고 안전하며 비발암성이며 변조가 분명하지 않아 이를 활용하는데 무리가 없다할 것이다.These vegetarian capsules are natural, GMO, vegetable shells and are free of animal derivatives, gluten and modified sugars. Vegetarian capsules today can be divided into several types: plant polysaccharide ( Pululan ), starch and HPMC ( Hydroxyl Propyl Methyl Celluloses ). Vegetarian capsules have the advantage of being suitable for halal or kosher certification. It has a pure, clean and elegant appearance without taste or smell, ideal for improving the bioavailability of useful ingredients, easy to swallow, safe, non-carcinogenic, and tamper-evident, so there is no difficulty in using it.
이와 같이, 본 발명은 금화규 속에서 취득한 콜라겐아미노산을 가장 효율적인 방법으로 온전하게 취득하여, 동물성 콜라겐의 취약한 점을 해소하면서도 관절 건강ㆍ피부노화 및 주름 개선 등에 효과가 있는 의약품 원료를 비롯하여 의약외품 원료ㆍ화장품 원료ㆍ기능성 식품원료 등지에 다양한 원료로 활용함은 물론 자유로운 제형의 변화를 손쉽게 추구할 수 있고, 특히 기능적ㆍ유기적 측면에서 콜라겐 합성을 돕는 피부 세포와 유사한 성분인 콜라겐아미노산(GPH; 글리신, 프롤린, 히드록시프롤린) 함량이 아주 높아 인체내 흡수율이 빠르고 피부 수분 양에 관여해 섭취 시 피부 노화와 관절 약화, 혈관 손상을 방지함은 물론 도포 시 피부 보습과 주름 개선되는 등 제품보존성과 안전성이 우수하다.In this way, the present invention completely acquires collagen amino acids obtained from Keumhwagyu in the most efficient way, thereby solving the weak points of animal collagen, while improving joint health, skin aging and wrinkles. It can be used as a variety of raw materials for cosmetic raw materials, functional food raw materials, etc., as well as free formulation changes can be easily pursued, and in particular, collagen amino acid (GPH; glycine, proline), a component similar to skin cells that helps collagen synthesis in functional and organic aspects , Hydroxyproline) content is very high, so the absorption rate in the body is fast, and it is involved in the amount of skin moisture, preventing skin aging, weakening of joints and blood vessel damage when ingested, as well as moisturizing the skin and improving wrinkles when applied, providing excellent product preservation and safety. .
본 발명은 기재된 실시예에 한정되는 것은 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명하다. 따라서 그러한 변형예 또는 수정예들은 본 발명의 특허청구범위에 속한다 해야 할 것이다.The present invention is not limited to the described embodiments, and it is obvious to those skilled in the art that various modifications and variations can be made without departing from the spirit and scope of the present invention. Therefore, such variations or modifications should fall within the scope of the claims of the present invention.
Claims (5)
상기 콜라겐 조성물은 화장품 조성물이고, 화장품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 화장품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 하는 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물.According to claim 1,
The collagen composition is a cosmetic composition, and contains 0.1 to 10% by weight of either a collagen amino acid extract or freeze-dried powder based on the total weight of the cosmetic composition, and the remaining amount is a carrier acceptable for cosmetic formulations 90 A functional collagen composition using collagen amino acids derived from goldfish, characterized in that it is contained in an amount of ~ 99.9% by weight.
상기 콜라겐 조성물은 식품 조성물이고, 식품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 식품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 하는 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물.According to claim 1,
The collagen composition is a food composition, and contains 0.1 to 10% by weight of either a collagen amino acid extract or freeze-dried powder based on the total weight of the food composition, and the remaining amount is a carrier acceptable for food formulations 90 A functional collagen composition using collagen amino acids derived from goldfish, characterized in that it is contained in an amount of ~ 99.9% by weight.
상기 콜라겐 조성물은 관절 건강ㆍ피부노화 및 주름 개선용 의약품 조성물이고, 의약품 조성물 전체 중량을 기준으로 하여 콜라겐아미노산 추출액 또는 동결 건조한 분말 중 어느 하나를 선택하여 0.1~10중량% 함유하고, 잔량(殘量)으로 의약품 제제에 허용되는 담체 90~99.9중량%의 함량으로 함유하는 것을 특징으로 하는 금화규 유래 콜라겐아미노산을 이용한 기능성 콜라겐 조성물.According to claim 1,
The collagen composition is a pharmaceutical composition for joint health, skin aging and wrinkle improvement, and contains 0.1 to 10% by weight of either a collagen amino acid extract or a freeze-dried powder based on the total weight of the pharmaceutical composition, and the remaining amount ) Functional collagen composition using collagen amino acid derived from goldfish, characterized in that it is contained in an amount of 90 to 99.9% by weight of a carrier acceptable for pharmaceutical formulations.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210016090A KR102511701B1 (en) | 2021-02-04 | 2021-02-04 | Functional collagen composition using collagen amino acid derived from Aurea Helianthus |
PCT/KR2021/015149 WO2022169066A1 (en) | 2021-02-04 | 2021-10-27 | Functional collagen composition using aurea helianthus-derived collagen amino acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210016090A KR102511701B1 (en) | 2021-02-04 | 2021-02-04 | Functional collagen composition using collagen amino acid derived from Aurea Helianthus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220112888A KR20220112888A (en) | 2022-08-12 |
KR102511701B1 true KR102511701B1 (en) | 2023-03-22 |
Family
ID=82741238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210016090A KR102511701B1 (en) | 2021-02-04 | 2021-02-04 | Functional collagen composition using collagen amino acid derived from Aurea Helianthus |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102511701B1 (en) |
WO (1) | WO2022169066A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102565639B1 (en) | 2023-01-31 | 2023-08-11 | 주식회사 창의씨앤알 | Plant derived collagen peptide composition and composition comprising the same |
KR102694251B1 (en) * | 2023-05-17 | 2024-08-12 | 연규한 | Method for food extract collagen from golden hibiscus leaves |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101278600B1 (en) * | 2011-12-29 | 2013-06-25 | 대한민국 | Rice-bran extract of giant embryo, milyang263, containing gaba and amino acids and composition containing its extract |
KR101846503B1 (en) | 2016-11-23 | 2018-05-18 | 농업회사법인포포나무 주식회사 | Composition for Preventing Hair Loss or Improving Hair Growth Hibiscus and Pawwpaw |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2801313A1 (en) | 1999-05-19 | 2001-05-25 | Coletica | COLLAGENIC PRODUCT CONTAINING COLLAGEN OF MARINE ORIGIN WITH LOW ODOR AND PREFERREDLY WITH IMPROVED MECHANICAL PROPERTIES, AS WELL AS ITS USE IN THE FORM OF COMPOSITIONS OR COSMETIC OR PHARMACEUTICAL PRODUCTS |
KR20040014618A (en) | 2004-01-16 | 2004-02-14 | 최희환 | Production method of functional beverage using collagen and acanthopanacis cortex |
KR100827389B1 (en) | 2007-01-02 | 2008-05-06 | 씨엔에이바이오텍(주) | Composition of collagen peptides for food and method thereof |
KR101248617B1 (en) * | 2010-12-30 | 2013-03-28 | 한국식품연구원 | A method of extracting collagen by ultrasonication |
KR101783469B1 (en) * | 2015-09-07 | 2017-09-29 | 청양포포나무농장영농조합법인 | Extraction method of collagens from plant |
-
2021
- 2021-02-04 KR KR1020210016090A patent/KR102511701B1/en active IP Right Grant
- 2021-10-27 WO PCT/KR2021/015149 patent/WO2022169066A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101278600B1 (en) * | 2011-12-29 | 2013-06-25 | 대한민국 | Rice-bran extract of giant embryo, milyang263, containing gaba and amino acids and composition containing its extract |
KR101846503B1 (en) | 2016-11-23 | 2018-05-18 | 농업회사법인포포나무 주식회사 | Composition for Preventing Hair Loss or Improving Hair Growth Hibiscus and Pawwpaw |
Also Published As
Publication number | Publication date |
---|---|
KR20220112888A (en) | 2022-08-12 |
WO2022169066A1 (en) | 2022-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101841255B1 (en) | Composition for improving skin wrinkle and enhancing elasticity | |
US8022038B2 (en) | Composition for acceleration of type I collagen production | |
US20100323044A1 (en) | Abnormal protein removing method | |
KR102511701B1 (en) | Functional collagen composition using collagen amino acid derived from Aurea Helianthus | |
JP5686328B2 (en) | Anti-glycation composition | |
JP2016160198A (en) | Kaempferia parviflora-containing compositions | |
JP2015127339A (en) | Composition for anti-saccharification | |
JP2008308505A (en) | Composition for removing abnormal protein | |
JP6765090B2 (en) | Black ginger-containing composition | |
JP6108352B2 (en) | Fatigue improving composition | |
JP2015025008A (en) | Anti-glycation composition | |
KR102655418B1 (en) | Method For Preparing Collagen Having Low Molecular Weight Derived From Antler | |
JP6607418B2 (en) | Anti-glycation composition | |
KR101415367B1 (en) | Harp seal collagen peptide, a method for manufacturing said halp seal collagen peptide and use of the same | |
JP6260804B2 (en) | Anti-glycation composition | |
KR101555234B1 (en) | The method for manufacuting momordica charantia, and the inclusion compound made by the method | |
JP7513299B2 (en) | Oral composition for inhibiting elastase and use thereof, elastase inhibitor, and method for inhibiting elastase activity by orally taking an elastase inhibitor | |
JP7217550B2 (en) | Composition containing black ginger | |
KR102508753B1 (en) | Method of Preparing Concentrate of Deer Antlers | |
JP6447848B2 (en) | Anti-glycation composition | |
KR20110080998A (en) | Composition for improving wrinkle and elasticity containing black currant anthocyanins | |
KR102209664B1 (en) | Composition for preventing or treating skin disease comprising extract of Euonymus alatus ciliatodentatus | |
KR102162843B1 (en) | Composition for preventing or treating skin disease comprising extract of Corylus heterophylla | |
JP6075434B2 (en) | Anti-glycation composition | |
JP2024010064A (en) | Anti-inflammatory agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |